Hydration Pharmaceuticals Co Ltd
ASX:HPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
AU |
|
D
|
DO & CO AG
XMUN:DOQ
|
AT |
Intrinsic Value
The intrinsic value of Hydration Pharmaceuticals Co Ltd (HPC) under the Base Case is 0.005 AUD per share. Compared with the current market price of 0.003 AUD, the stock appears Undervalued by 34% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Hydration Pharmaceuticals Does
The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The firm is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The firm markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand.
- Headquarters
- Australia AU
- IPO date
- Dec 14, 2021
Earnings Waterfall
Hydration Pharmaceuticals Co Ltd
The intrinsic value for Hydration Pharmaceuticals Co Ltd (HPC) under the Base Case is 0.005 AUD.
Compared with the current market price of 0.003 AUD, the stock appears Undervalued by 34% .